27 May 2013

Another property of rapamycin

It has been established how rapamycin slows down cell growth

ABC MagazineResearchers from the University of Montreal have discovered a new molecular mechanism that is theoretically capable of slowing the progression of cancer and other diseases caused by excessive cell growth.

In their article published in the journal Cell (Messier et al., A Nutrient-Responsive Pathway that Determines M Phase Timing through Control of B-Cyclin mRNA Stability), the researchers explain how the well-known immunosuppressant rapamycin slows down cell division.

As the author of the study, professor of biochemistry, Dr. Stephen Michnick, explains, dividing cells constantly monitor the presence and quantity of available nutrients, and when they are deficient, they begin to slow down division and growth. A protein called the "rapamycin target" (TOR) helps cells in this tracking, but scientists have not known for a long time exactly how this protein affects the division processes.

In the course of the study, Dr. Michnik and his colleagues found that as soon as cells begin to lack nutrients, TOR synthesizes a small protein signaling molecule. It stops the formation of mRNA synthesizing B-cyclin. This regulator of the cell cycle sends a signal to the cells, forcing them to stop dividing.

Thus, rapamycin is becoming a promising drug for the treatment of certain types of cancer and other proliferative diseases, for example, lymphangioleiomyomatosis.

Portal "Eternal youth" http://vechnayamolodost.ru27.05.2013

Found a typo? Select it and press ctrl + enter Print version